Información del artículo
El Texto completo está disponible en PDF
Bibliogrífia
[1.]
D.M. Eisenberg, R.C. Kessler, C. Foster, F.E. Norlock, D.R. Calkins, T.L. Delbanco.
Unconventional medicine in the United States. Prevalence, costs and patterns of use.
N Engl J Med, 328 (1993), pp. 246-252
[2.]
A. Richman, J. Witkowski.
Herbs by the numbers.
Whole Foods Magazine, 20 (1997),
[3.]
B.A. Johnston.
One-third of nation’s adults use herbal remedies.
Herbalgram, 43 (1997), pp. 40-49
[4.]
P. Brevoort.
The booming US botanical market. A new overview.
Helbagram, 44 (1998), pp. 33-46
[6.]
M.K. Ang-Lee, J. Moss, C.S. Yuan.
Herbal medicines and perioperative care.
JAMA, 286 (2001), pp. 208-216
[7.]
H.B. Matthews, G.W. Lucier, K.D. Fisher.
Medicinal herbs in the United States.
Environ Health Perspect, 107 (1999), pp. 773-778
[8.]
R. Edwards.
Monitoring the safety of herbal medicines. WHO project is underway.
BMJ, 311 (1995), pp. 1569-1570
[9.]
Herbal Rx-the promises and pitfalls.
Consumer Report, (March 1999), pp. 44-48
[10.]
L. Perharic, D. Shaw, V. Murray.
Toxic effects of herbal medications and food supplements.
Lancet, 342 (1993), pp. 180-181
[11.]
J. Barnes, S.Y. Mills, N.C. Abbot, M. Willoughby, E. Ernst.
Different standards for reporting ADRs to herbal medicines and conventional OTC medicines: face-to-face interviews with 515 users of herbal medicines.
Br J Clin Pharmacol, 45 (1998), pp. 496-500
[12.]
R.J. Huxtable.
The myth of beneficent nature: the risks of herbal preparations.
Ann Int Med, 117 (1992), pp. 164-165
[13.]
S. Nogué, P. Sanz, A. Botey, N. Esforzado, C. Blanche, L. Álvarez.
Insuffisance rénale aigüe due à une intoxication par le chardon à glu (Atractylis gummífera-L).
Nov Presse Med, 21 (1992), pp. 130
[14.]
A. Ortiz, E. Crespo, P. Morales, J. Sáenz de Santamaría, J.M. González, T. Ruiz.
Enfermedad venooclusiva hepática por ingestión de infusiones de Senecio vulgaris.
Gastroenterol Hepatol, 18 (1995), pp. 413-416
[15.]
J.C. Gavilán, F.J. Bermúdez, F. Salgado, D. Peña.
Fitoterapia y hepatitis.
Rev Clin Esp, 199 (1999), pp. 693-694
[16.]
J.C. Pérez Álvarez, F. Sáez-Royuela, E. Gento Peña, A. López Morante, A. Velasco Osés, J.L. Martín Lorente.
Hepatitis aguda por ingestión de infusiones con Teucrium chamaedrys.
Gastroenterol Hepatol, 24 (2001), pp. 240-243
[17.]
D. Larrey, G.P. Pageaux.
Hepatotoxicity of Herbal remedies and mushrooms.
Sem Liver Dis, 15 (1995), pp. 183-188
[19.]
H.J. Zimmmerman.
Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver.
[20.]
L.W. Smith.
Culvenor CCJ. Plant sources of hepatotoxic pirrolizidine alkaloids.
J Nat Prod, 44 (1981), pp. 129-152
[21.]
C.C.J. Culvenor, J.A. Edgar, L.W. Smith, C.R. Kumana, H.J. Lin.
Heliotropium lasiocarpium fish and mey identified as cause of veno-occlusive disease due to a herbal tea.
Lancet, 1 (1986), pp. 978
[22.]
P.J. Grases, S.G. Beker.
Veno-occlusive disease of the liver: a case from Venezuela.
Am J Med, 53 (1972), pp. 511-516
[23.]
A.S. Stillman, R. Huxtable, P. Consroe, P. Kohnen, S. Smith.
Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona.
Gastroenterology, 73 (1977), pp. 349-352
[24.]
D.W. Fox, M.C. Hart, P.S. Bergeson, P.B. Jarret, A.E. Stillman, R.J. Huxtable.
Pyrrolizidine (Senecio) intoxication mimicking Reye’s syndrome.
J Pediatrics, 93 (1978), pp. 980-982
[25.]
J.H. Vilar, M. García, P. Cabrera.
Enfermedad venooclusiva hepática de causa tóxica por Senecio vulgaris.
Gastroenterol Hepatol, 23 (2000), pp. 285-286
[26.]
C.F.M. Weston, B.T. Cooper, J.D. Davies, D.F. Levine.
Veno-occlusive disease of the liver secondary to ingestion of comfrey.
BMJ, 295 (1987), pp. 183
[27.]
N. Bach, S.N. Thung, F. Schaffner.
Comfrey herb tea-induced hepatic veno-occlusive disease.
Am J Med, 87 (1989), pp. 97-99
[28.]
P.M. Ridker, V. McDermott.
Comfrey herb tea and hepatic venoocclusive disease.
Lancet, 7 (1989), pp. 657-658
[29.]
J.A. Solís-Herruzo, J.A. Vidal-Ruiz.
Enfermedad venooclusiva del hígado.
Med Clin (Barc), 84 (1985), pp. 146-149
[30.]
D. Valla, J.P. Benhamou.
Drug-induced vascular and sinusoidal lesions of the liver.
Clin Gastroenterol, 2 (1988), pp. 481-500
[31.]
C.R. Kumana, M. Ng, H.J. Lin, W. Ko, P-C. Wu, D. Todd.
Herbal tea induced hepatic veno-occlusive disease: quantification of toxic alkaloid exposure in adults.
Gut, 26 (1985), pp. 101-104
[32.]
R.J. Huxtable.
New aspects of the toxicology of pyrrolizidine alkaloids.
Mol Pharmacol, 10 (1979), pp. 159-167
[33.]
L. DeLeve, X. Wang, J. Kuhlenkamp, N. Kaplowitz.
Selective toxicity to sinusoidal endothelial cells by agents that cause hepatic veno-occlusive disease is modulated by GSH: azathioprine and monocrotaline.
Hepatology, 23 (1996), pp. 589-599
[34.]
D. Larrey, T. Vial, A. Pawels, A. Castot, M. Biour, M. David, et al.
Hepatitis after Germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity.
Ann Int Med, 117 (1992), pp. 129-132
[35.]
A. Castot, D. Larrey.
Hépatites observées au cours d’un traitement par un medicament ou une tisane contenant de la Germandree petit-chêne. Bilan des 26 cas rapports aux centres Régionaux de Pharmacovigilance.
Gastroenterol Clin Biol, 16 (1992), pp. 916-922
[36.]
N. Mostefa-Kara, A. Pauwels, E. Pines, M. Biour, V.G. Levy.
Fatal hepatitis after herbal tea.
Lancet, 340 (1992), pp. 674
[37.]
D. Díaz, S. Ferroudji, B. Heran, G. Barneon, D. Larrey, H. Michel.
Hépatite aigüe à la germandrée petit-chêne.
Gastroenterol Clin Biol, 16 (1992), pp. 1006-1007
[38.]
M. Ben Yahia, P. Mavier, J.M. Metreau, E.S. Zafrani, M. Fabre, Gatienau-Sailant, et al.
Hépatite chronique active et cirrhose induites par la germandrée petit-chêne à propos de tríos cas.
Gastroenterol Clin Biol, 17 (1993), pp. 959-962
[39.]
J. Loeper, V. Descatoire, P. Letteron, C. Moulis, C. Degott, P. Dansette, et al.
Hepatotoxicity of Germander in mice.
Gastroenterology, 106 (1994), pp. 464-472
[40.]
D. Fau, M. Lekehal, G. Farrel, A. Moreau, C. Moulis, G. Feldmann, et al.
Diterpenoids from Germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes.
Gastroenterology, 113 (1997), pp. 1334-1346
[41.]
R.J. Andrade, M.I. Lucena.
¿Es inevitable la hepatotoxicidad inducida por fármacos?.
Rev Esp Enferm Dig, 93 (2001), pp. 48-53
[42.]
G. Lemaigre, Z. Tebbi, R. Galinsky, S. Michowitcz, R. Abelanet.
Hépatite fulminante par intoxication due au charbon à glue (Atractylis gummífera-L).
Nouv Presse Med, 4 (1975), pp. 2865
[43.]
M. Georgiou, L. Sianidou, T. Hatzis, J. Papadatos, A. Koutselinis.
Hepatotoxicity due to Atractylis gummífera-L.
Clin Toxicol, 26 (1989), pp. 487-493
[44.]
A. Heidili, J.M. Warnet, M. Thevenin, C. Martin, M. Yacoub, J.R. Claude.
Biochemical investigation of Atractylis gummífera-L hepatotoxicity in the rat.
Arch Toxicol, 13 (1989), pp. 312-315
[45.]
K.P. Mokhobo.
Herbs use and necro-degenerative hepatitis.
S Afr Med J, 50 (1976), pp. 1096-1099
[46.]
E.M. Yoshida, C.A. McLean, E.S. Cheng, P.D. Blanc, K.A. Somberg, L.D. Ferrell, et al.
Chines herbal medicine, fulminant hepatitis and liver transplantation.
Am J Med, 91 (1996), pp. 2647-2648
[47.]
T.Y.K. Chan, J.C.N. Chan, B. Tomlinson.
Critchley AJH. Chinese herbal medicines revisited: a Hong-Kong perspective.
Lancet, 342 (1993), pp. 1532-1534
[48.]
K.G. Davies, I. Pollock, H.M. Steel.
Chinese herbs for eczema.
Lancet, 336 (1990), pp. 177
[49.]
M.P. Sheehan, M.H. Rustin, D.J. Atherton, C. Buckley, D.J. Harris, J. Brostoff, et al.
Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis.
Lancet, 340 (1992), pp. 13-17
[50.]
M.P. Sheehan, D.J. Atherton.
One year follow-up of children with atopic eczema treated with traditional Chinese medicinal plants.
Br J Dermatol, 127 (1992), pp. 13
[51.]
L. Perharic-Walton, V. Murray.
Toxicity of Chinese herbal remedies.
Lancet, 340 (1992), pp. 674
[52.]
A. Nadir, S. Agrawal, P.D. King, J.B. Marshall.
Acute hepatitis associated with the use of a Chinese herbal product, Ma-huang.
Am J Gastroenterol, 91 (1996), pp. 1436-1438
[53.]
M. Levi, H.J. Guchelaar, H.J. Woerdenbag, Y.P. Zhu.
Acute hepatitis in a patient using Chinese herbal tea-a case report.
Pharm World Sci, 20 (1998), pp. 43-44
[54.]
D. Shaw, C. Leon, S. Kolev, V. Murray.
Traditional remedies and food supplements. A 5-year Toxicological study (1991-1995).
Drug Safe, 17 (1995), pp. 342-346
[55.]
G.M. Woolf, L.M. Petrovic, S.E. Rojter, S. Wainwright, F.G. Villamil, W.N. Katkov, et al.
Acute hepatitis associated with the herbal product Jin Bu Huan.
Ann Intern Med, 121 (1994), pp. 729-735
[56.]
I. Greving, V. Meister, C. Monnerjahn, K.M. Müller, B. May.
Chelidonium majus: a rare reason for severe hepatotoxic reaction.
Pharmacoepidemiol Drug Safety, 7 (1998), pp. S66-S69
[57.]
V. Strahl S Ehret, H.H. Dahm, K.P. Maier.
Nekrotisierende Hepatitis nach, Einnahme pflanzlicher Heilmittel.
Dtsch Med Wochenschr, 123 (1998), pp. 1410-1414
[58.]
P.A. De Smet, A.J. Van den Eertwegh, W. Lesterhuis, B.H. Striker.
Hepatotoxicity associated with herbal tablets.
BMJ, 313 (1996), pp. 92
[59.]
J. Benninger, H.T. Scheinder, D. Schuppan, T. Kirchner, E.G. Hahn.
Acute hepatitis induced by greater celandine (Chelidonium majus).
Gastroenterology, 117 (1999), pp. 1234-1237
[60.]
U. Bauers, U. Splenger, G.R. Pape.
Hepatitis after chronic abuse of senna.
Lancet, 337 (1991), pp. 372-373
[61.]
M.I. Lucena, R. Camargo, R.J. Andrade, C. Pérez-Sánchez, F. Sánchez de la Cuesta.
Comparison of two clinical scales for causality assessment in hepatotoxicity.
Hepatology, 33 (2001), pp. 123-130
[62.]
K.G. Tolman, S. Hammar, J.J. Sannella.
Possible hepatotoxicity of Doxidan.
Ann Intern Med, 84 (1976), pp. 290-292
[63.]
A. Nadir, D. Reddy, D.H. Van Thiel.
Cascara Sagrada-induced intrahepatic cholestasis causing portal hypertension: a case report and review of herbal hepatotoxicity.
Am J Gastroenterol, 95 (2000), pp. 3634-3637
[64.]
M. Katz, F. Saibil.
Herbal hepatitis: subscute hepatic necrosis secondary to chaparral leaf.
J Clin Gastroenterol, 12 (1990), pp. 203-206
[65.]
W.J. Kassler, P. Blanc, R. Greenblatt.
The use of medicinal herbs by human immunodeficiency virus-infected patients.
Arch Intern Med, 151 (1991), pp. 2281-2288
[66.]
Anonymous.
Chaparral-induced toxic hepatitis. California and Texas.
MMWR, 41 (1992), pp. 812-814
[67.]
N.M. Sheikh, R.M. Philen, L.A. Love.
Chaparral-associated hepatotoxiciy.
Arch Intern Med, 157 (1997), pp. 913-919
[69.]
F.B. MacGregor, V.E. Abernethy, S. Dahabra, I. Cobden, P.C. Hayes.
Hepatotoxicity of herbal remedies.
BMJ, 299 (1989), pp. 1156-1157
[70.]
G.R. Weeks, J.S. Proper.
Herbal medicines. Gaps in our knowledge.
Aust J Hosp Pharm, 19 (1989), pp. 155-157
[71.]
A. Mattei, P. Rueay, D. Samuel, C. Feray, M. Reynes, H. Bismuth.
Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration.
J Hepatol, 22 (1995), pp. 597
[72.]
M. Escher, J. Desmeules, E. Giostra, G. Mentha.
Hepatitis associated with Kava, a herbal remedy for anxiety.
BMJ, 322 (2001), pp. 139
[73.]
L.B. Seef, K. Lindsay, B. Baco, T.F. Kresina, J.H. Hoofnagle.
Complementary and alternative medicine in chronic liver disease.
Hepatology, 34 (2001), pp. 595-603
[74.]
Herbal Medicines.
WHO Drug Information, 14 (2000), pp. 237-243
[75.]
L.G. Miller.
Herbal medicinals.
Arch Intern Med, 159 (1998), pp. 2200-2211
[76.]
A. Fugh-Berman.
Herb drug interactions.
Lancet, 355 (2000), pp. 134-138
Este estudio ha sido parcialmente financiado con fondos de la Agencia Española del Medicamento.
Copyright © 2002. Elsevier España, S.L.. Todos los derechos reservados
